45 results on '"Sneezing immunology"'
Search Results
2. EAACI Position paper on the standardization of nasal allergen challenges.
- Author
-
Augé J, Vent J, Agache I, Airaksinen L, Campo Mozo P, Chaker A, Cingi C, Durham S, Fokkens W, Gevaert P, Giotakis A, Hellings P, Herknerova M, Hox V, Klimek L, La Melia C, Mullol J, Muluk NB, Muraro A, Naito K, Pfaar O, Riechelmann H, Rondon C, Rudenko M, Samolinski B, Tasca I, Tomazic P, Vogt K, Wagenmann M, Yeryomenko G, Zhang L, and Mösges R
- Subjects
- Administration, Intranasal, Aftercare, Anaphylaxis, Germany, Humans, Immunoglobulin E blood, Nasal Mucosa immunology, Nasal Obstruction immunology, Nasal Provocation Tests methods, Nasal Sprays, Pruritus immunology, Skin Tests, Sneezing immunology, Advisory Committees, Allergens administration & dosage, Nasal Provocation Tests standards, Nasal Provocation Tests trends, Rhinitis, Allergic diagnosis
- Abstract
Nasal allergen challenge (NAC) is an important tool to diagnose allergic rhinitis. In daily clinical routine, experimentally, or when measuring therapeutic success clinically, nasal allergen challenge is fundamental. It is further one of the key diagnostic tools when initiating specific allergen immunotherapy. So far, national recommendations offered guidance on its execution; however, international divergence left many questions unanswered. These differences in the literature caused EAACI to initiate a task force to answer unmet needs and find a consensus in executing nasal allergen challenge. On the basis of a systematic review containing nasal allergen challenges of the past years, task force members reviewed evidence, discussed open issues, and studied variations of several subjective and objective assessment parameters to propose a standardized way of a nasal allergen challenge procedure in clinical practice. Besides an update on indications, contraindications, and preparations for the test procedure, main recommendations are a bilaterally challenge with standardized allergens, with a spray device offering 0.1 mL per nostril. A systematic catalogue for positivity criteria is given for the variety of established subjective and objective assessment methods as well as a schedule for the challenge procedure. The task force recommends a unified protocol for NAC for daily clinical practice, aiming at eliminating the previous difficulty of comparing NAC results due to unmet needs., (© 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
3. Intranasal exposure to monoclonal antibody Fab fragments to Japanese cedar pollen Cry j1 suppresses Japanese cedar pollen-induced allergic rhinitis.
- Author
-
Yoshino S and Mizutani N
- Subjects
- Administration, Intranasal, Animals, Antibodies, Monoclonal immunology, Immunoglobulin Fab Fragments immunology, Male, Mice, Mice, Inbred BALB C, Nasal Mucosa immunology, Sneezing immunology, Antibodies, Monoclonal administration & dosage, Antibodies, Monoclonal therapeutic use, Immunoglobulin Fab Fragments administration & dosage, Immunoglobulin Fab Fragments therapeutic use, Pollen immunology, Rhinitis, Allergic drug therapy, Rhinitis, Allergic immunology
- Abstract
Background and Purpose: Fab fragments (Fabs) of antibodies have the ability to bind to specific allergens but lack the Fc portion that exerts effector functions via binding to receptors including FcεR1 on mast cells. In the present study, we investigated whether intranasal administration of the effector function-lacking Fabs of a monoclonal antibody IgG1 (mAb, P1-8) to the major allergen Cry j1 of Japanese cedar pollen (JCP) suppressed JCP-induced allergic rhinitis in mice., Experimental Approach: Balb/c mice sensitized with JCP on days 0 and 14 were challenged intranasally with the pollen on days 28, 29, 30 and 35. Fabs prepared by the digestion of P1-8 with papain were also administered intranasally 15 min before each JCP challenge., Key Results: Intranasal administration of P1-8 Fabs was followed by marked suppression of sneezing and nasal rubbing in mice with JCP-induced allergic rhinitis. The suppression of these allergic symptoms by P1-8 Fabs was associated with decreases in mast cells and eosinophils and decreased hyperplasia of goblet cells in the nasal mucosa., Conclusions and Implications: These results demonstrated that intranasal exposure to P1-8 Fabs was effective in suppressing JCP-induced allergic rhinitis in mice, suggesting that allergen-specific mAb Fabs might be used as a tool to regulate allergic pollinosis., (© 2016 The British Pharmacological Society.)
- Published
- 2016
- Full Text
- View/download PDF
4. Production of Rice Seed-Based Allergy Vaccines.
- Author
-
Takagi H and Takaiwa F
- Subjects
- Administration, Oral, Allergens administration & dosage, Animals, CD4-Positive T-Lymphocytes cytology, CD4-Positive T-Lymphocytes immunology, CD4-Positive T-Lymphocytes metabolism, Cytokines metabolism, Granulocytes immunology, Histamine immunology, Hypersensitivity prevention & control, Immunoglobulin E immunology, Immunoglobulin G immunology, Mice, Nasal Lavage Fluid immunology, Sneezing immunology, Spleen immunology, Vaccines administration & dosage, Allergens immunology, Hypersensitivity immunology, Oryza chemistry, Seeds immunology, Vaccines immunology
- Abstract
Recombinant hypoallergenic derivative is the next generation of tolerogen replacing the natural allergen extract to increase safety and efficacy. Japanese cedar pollinosis is the predominant seasonal allergy disease in Japan. A rice seed-based oral vaccine containing the recombinant hypoallergens derived from these allergens was developed. Efficacy of this rice-based allergy vaccine was evaluated by oral administration in animal models.
- Published
- 2016
- Full Text
- View/download PDF
5. Effect of Asian sand dust on Japanese cedar pollinosis.
- Author
-
Ogi K, Takabayashi T, Sakashita M, Susuki D, Yamada T, Manabe Y, and Fujieda S
- Subjects
- Adult, Humans, Japan, Young Adult, Allergens immunology, Cryptomeria, Dust immunology, Environmental Exposure statistics & numerical data, Pollen immunology, Rhinitis, Allergic, Seasonal immunology, Seasons, Sneezing immunology
- Abstract
Objective: Asian sand dust (ASD), originating in the deserts of Mongolia and China, spreads over large areas and is associated with adverse effects on human health in East Asia, including asthma, heart disease, and some allergic diseases. However, the effect of ASD on patients with seasonal allergic rhinitis caused by Japanese cedar pollen (SAR-JCP), the most common form of allergic rhinitis, remains unclear. The aim of this study was to investigate the effect of ASD on SAR-JCP patients., Methods: A total of 41 patients with SAR-JCP recorded nasal and ocular allergic symptom scores in a diary. We assessed the influence of ASD events on patients with SAR-JCP during the JCP season and before and after the JCP season., Results: ASD events did not influence nasal and ocular allergy symptoms during the JCP season. Scores for sneezing and runny nose were significantly increased by ASD events in the pre-JCP season. Ocular symptom scores were significantly increased by ASD events in the post-JCP season., Conclusion: Our results suggest that ASD may exacerbate allergy symptoms even before mass scattering of JCP, which usually does not cause allergic symptoms in patients with SAR-JCP. ASD also induced conjunctivitis symptoms after the JCP season. However, we did not observe any adverse effects of ASD on allergic symptoms during the JCP season., (Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
6. Not to be sneezed at.
- Author
-
McManus L and Hosie P
- Subjects
- Adolescent, Child, Humans, Prevalence, Rhinitis, Allergic, Seasonal epidemiology, Sneezing immunology, United Kingdom epidemiology, Allergens immunology, Immunotherapy methods, Rhinitis, Allergic, Seasonal therapy
- Published
- 2014
7. A proof-of-concept study of the effect of a novel H3-receptor antagonist in allergen-induced nasal congestion.
- Author
-
Barchuk WT, Salapatek AM, Ge T, D'Angelo P, and Liu X
- Subjects
- Adolescent, Adult, Aged, Allergens, Ambrosia adverse effects, Azepines administration & dosage, Cross-Over Studies, Female, Histamine H3 Antagonists administration & dosage, Humans, Male, Middle Aged, Pyridines administration & dosage, Rhinitis, Allergic, Seasonal immunology, Rhinometry, Acoustic, Sneezing immunology, Treatment Outcome, Young Adult, Ambrosia immunology, Azepines therapeutic use, Histamine H3 Antagonists therapeutic use, Nasal Obstruction drug therapy, Pyridines therapeutic use, Rhinitis, Allergic, Seasonal drug therapy
- Abstract
Background: H1-receptor inverse agonists are used effectively for treating several symptoms of allergic rhinitis, including nasal itching, rhinorrhea, and sneezing, although most agents are not very effective in treating nasal congestion., Objective: This study evaluated the relative efficacy of a novel selective H3-receptor antagonist, JNJ-39220675, in preventing nasal congestion induced by exposing participants with ragweed allergy to ragweed allergen in an environmental exposure chamber model., Methods: In this single-dose, patient-blind, double-dummy, placebo- and active-controlled, phase IIa cross-over study, 53 participants were randomized to JNJ-39220675 plus placebo, placebo plus pseudoephedrine, or only placebo. The primary efficacy assessment was change in nasal patency assessed by measuring the minimal cross-sectional area of the nasal cavity by using acoustic rhinometry. Secondary assessment included total nasal symptom scores (TNSSs) over the 8-hour environmental exposure chamber exposure period., Results: Smaller decreases in minimal cross-sectional area were observed after JNJ-39220675 (least square mean difference, -0.126; P = .06) and pseudoephedrine (least square mean difference, -0.195; P = .004) treatment compared with placebo. The means for the baseline-adjusted area under the curve of TNSSs were significantly smaller for JNJ-39220675 (P = .0003) and pseudoephedrine (P = .04) versus placebo. JNJ-39220675 was significantly effective in treating all 4 individual symptoms (P ≤ .05 for all scores) compared with placebo, whereas pseudoephedrine only showed a trend for improvement in individual symptom scores of the TNSS. Insomnia was the most frequent adverse event (17.3%) associated with JNJ-39220675 treatment., Conclusion: Prophylactic treatment with the H3-antagonist JNJ-39220675 relieved allergen-induced nasal congestion by using standard nasal symptom scoring; however, in contrast to pseudoephedrine, it only showed a trend for increasing nasal patency by using objective measures., (Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
8. When sneezing indicates the cell type.
- Author
-
Gelardi M, Quaranta N, and Passalacqua G
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Pollen adverse effects, Pollen immunology, Prognosis, Sneezing immunology, Young Adult, Eosinophils immunology, Nasal Polyps immunology, Rhinitis, Allergic, Seasonal immunology, Rhinitis, Vasomotor diagnosis, Rhinitis, Vasomotor immunology
- Abstract
Background: Nasal hyperreactivity is the symptomatic expression of vasomotor rhinitis. This study describes a typical nasal reaction, represented by a "volley of sneezes" found in some patients during nasal endoscopy, and to assess the possible correlation between hyperreactivity and a particular clinical and cytological condition., Methods: We studied 671 rhinological subjects, 344 male, mean age 35.7 ± 13.76 standard deviation (SD) years. All were submitted to medical histories and clinical and instrumental investigations (skin prick test, nasal endoscopy, and nasal cytology). While performing endoscopy, particular attention was paid to the possible signs of nasal hyperreactivity, in particular "volley of sneezes" both during and immediately after the diagnostic procedure., Results: Out of 671 endoscopies performed, 130 (17.1%) patients presented signs of hyperreactivity during and/or immediately after nasal endoscopy. The ratio of positive vasomotor reaction was 10.6% in the nasal polyposis (NP) group, 19% in the allergic rhinitis (AR) group, 70.6% (p < 0.01) in nonallergic rhinitis with mast cells (NARMA), 76% (p < 0.01) in nonallergic rhinitis with eosinophils and mast cells (NARESMA), and 83% (p < 0.01) in nonallergic rhinitis with eosinophils (NARES). In the AR subjects hyperreactivity was more frequent during the pollen season, compared to the period of absence of pollen (87.5% vs 12%)., Conclusion: The onset of hyperreactivity (sneezing) can be considered an important "sign" in nasal symptomatology, whose sensitivity and specificity for nonallergic "cellular" rhinitis are 79% and 93%, respectively., (© 2013 ARS-AAOA, LLC.)
- Published
- 2013
- Full Text
- View/download PDF
9. Therapeutic effects of β1, 4 mannobiose in a Balb/c mouse model of intranasally-induced pollen allergy.
- Author
-
Yang C, Rupa P, Kanatani H, Nakamura A, Ibuki M, and Mine Y
- Subjects
- Allergens administration & dosage, Allergens immunology, Animals, Cell Line, Cytokines biosynthesis, Cytokines immunology, Disease Models, Animal, Female, Gene Expression, Histamine blood, Immunoglobulin A immunology, Immunoglobulin E blood, Immunoglobulin E immunology, Immunoglobulin G blood, Immunoglobulin G immunology, Mice, Mice, Inbred BALB C, Peyer's Patches immunology, Peyer's Patches metabolism, Pollen immunology, Prebiotics, Rats, Rhinitis, Allergic, Seasonal genetics, Rhinitis, Allergic, Seasonal immunology, Sneezing immunology, Spleen immunology, Spleen metabolism, Mannans administration & dosage, Rhinitis, Allergic, Seasonal drug therapy
- Abstract
Background: Nutritional prebiotic supplementation represents an attractive approach for interventions of allergy. In this study, the potential therapeutic effect of β-1, 4 mannobiose (MNB) in a murine model of cedar pollinosis was investigated., Methods: Groups of Balb/c mice were intranasally sensitized to Japanese cedar pollen extract, and subsequently administered with low or high dose MNB. Both intraperitoneal and intranasal challenges were performed to monitor for clinical signs. Frequency of sneezing was recorded. Serum, spleen and Peyer's patches were collected for various biomarker analyses. Anti-allergic activity of MNB using RBL-2H3 cells was also evaluated., Results: Significant decrease in sneezing frequency, histamine, interleukin (IL)-4 and IL-17A and increase in TGF-β and IL-10 concentration were exhibited by the MNB-treated mice. However, Cry j1 and Cry j 2-specific IgE activity remained unaltered. The high dose MNB treatment increased total IgA activity and IL-10, TGF-β and FoxP3 and decreased IL-4, IL-17A, and RORγT mRNA expression. Inhibition of activation of RBL-2H3 cells was observed via decrease in histamine, intracellular Ca2+ concentration, and FcεRI mRNA expression., Conclusions: We demonstrated the immunomodulatory effects of MNB and conclude that MNB is a potential therapeutic molecular nutritional supplement candidate for treatment of pollen allergy.
- Published
- 2013
- Full Text
- View/download PDF
10. Effect of 5-aminosalicylate on allergic rhinitis model in mice.
- Author
-
Kuyama S, Yamamoto A, Sugiyama M, Kakuta H, and Sugimoto Y
- Subjects
- Aluminum Hydroxide immunology, Animals, Female, Histamine pharmacology, Immunoglobulin E blood, Interleukin-10 analysis, Interleukin-10 immunology, Interleukin-4 analysis, Interleukin-4 immunology, Mice, Mice, Inbred BALB C, Nasal Lavage Fluid chemistry, Nasal Lavage Fluid immunology, Ovalbumin immunology, Sneezing drug effects, Sneezing immunology, Anti-Allergic Agents therapeutic use, Mesalamine therapeutic use, PPAR gamma agonists, Rhinitis, Allergic, Perennial prevention & control
- Abstract
Previous studies have shown that peroxisome proliferator-activated receptor gamma (PPARgamma) is involved in allergic rhinitis. It has been reported that 5-aminosalicylate (5-ASA) has an affinity for PPARgamma, but the effects of 5-ASA on the nasal symptoms of allergic rhinitis are unclear. This study aimed to clarify the effects of 5-ASA on nasal symptoms in an allergic rhinitis model in mice. Female BALB/c mice were sensitized by intraperitoneal injection of ovalbumin (OVA) and aluminium hydroxide hydrate gel (alum) on days 0, 5, 14 and 21. Seven days later, mice were sensitized by the intranasal application of OVA thrice a week. 5-ASA was also administered orally after instillation of the antigen from day 28. The severity of allergic rhinitis was assessed by determining the extent of 2 nasal allergic symptoms-sneezing and nasal rubbing. In addition, serum OVA-specific immunoglobulin E (IgE) antibody, interleukin (IL)-4, and IL-10 levels in nasal lavage fluid and histamine sensitivity were determined. Repeated oral administration of 5-ASA attenuated the progression of nasal symptoms in sensitized mice in a dose-dependent manner. Additionally, 5-ASA prevented an increase in histamine sensitivity. Finally, 5-ASA inhibited both OVA-specific IgE antibody and IL-4 production; however, it had no effect on IL-10 levels. These results indicate that 5-ASA has a prophylactic effect on allergic rhinitis., (Copyright 2010 Elsevier B.V. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
11. Characterization of anti-inflammatory properties and evidence for no sedation liability for the novel antihistamine SUN-1334H.
- Author
-
Mandhane SN, Shah JH, Bahekar PC, Mehetre SV, Pawar CA, Bagad AS, Chidrewar GU, Rao CT, and Rajamannar T
- Subjects
- Acetates therapeutic use, Anaphylaxis drug therapy, Animals, Anti-Inflammatory Agents, Non-Steroidal therapeutic use, Ataxia chemically induced, Ataxia drug therapy, Cetirizine adverse effects, Cetirizine therapeutic use, Drug Interactions, Female, Guinea Pigs, Histamine H1 Antagonists, Non-Sedating therapeutic use, Hydroxyzine immunology, Hydroxyzine metabolism, Hydroxyzine therapeutic use, Immunoglobulin G blood, Interleukin-4 antagonists & inhibitors, Interleukin-4 immunology, Leukocytes drug effects, Leukocytes immunology, Loratadine adverse effects, Loratadine analogs & derivatives, Loratadine therapeutic use, Male, Mice, Mice, Inbred BALB C, Nasal Lavage Fluid chemistry, Nasal Lavage Fluid immunology, Nasal Mucosa immunology, Nasal Mucosa pathology, Pentobarbital pharmacology, Piperazines therapeutic use, Sneezing drug effects, Sneezing immunology, Terfenadine adverse effects, Terfenadine analogs & derivatives, Terfenadine therapeutic use, Acetates adverse effects, Alcohols administration & dosage, Anti-Inflammatory Agents, Non-Steroidal adverse effects, Histamine H1 Antagonists, Non-Sedating adverse effects, Hypersensitivity drug therapy, Piperazines adverse effects
- Abstract
Background: The anti-inflammatory potential of antihistamines has significant clinical utility. Long-term pharmacotherapy of so-called 'safe' antihistamines may be hampered by side effects in the central nervous system. In the present study, the new potential antihistamine SUN-1334H was compared with different antihistamines for anti-inflammatory effects, sedation potential and interaction with alcohol., Method: Nasal and skin allergy were induced in guinea pig and mice by ovalbumin sensitization and challenge. Neurogenic nasal inflammation was induced by capsaicin. Sedation potential and interaction with alcohol were assessed by i.v. and intracerebroventricular pentobarbital-induced sedation and alcohol-induced ataxia models., Results: Ovalbumin sensitization and challenge caused rhinitis pathology including inflammatory cell infiltration, IL-4, and protein leakage in the nasal lavage fluid (NLF) and presence of inflammatory cells in nasal epithelium. A 5-day treatment of antihistamines reduced these markers of inflammation. SUN-1334H, cetirizine and hydroxyzine caused comparable inhibition of NLF leukocytes, IL-4 and total protein concentrations. Fexofenadine and desloratadine showed moderate inhibition of NLF leukocytes and had no significant effect on IL-4 concentration. While fexofenadine had no effect on total protein concentration, the effect of desloratadine was comparable with the other antihistamines. In neurogenic nasal inflammation induced by capsaicin, SUN-1334H and fexofenadine caused better inhibition at lower and middle dose levels than the other antihistamines. In skin allergy models, SUN-1334H showed potent reduction of passive and active cutaneous anaphylactic reactions. In central nervous system side effects models, SUN-1334H, desloratadine and fexofenadine were devoid of any significant effects., Conclusions: The results are suggestive of a high anti-inflammatory to sedation index of SUN-1334H among leading antihistamines.
- Published
- 2010
- Full Text
- View/download PDF
12. Effects of endogenous glucocorticoids on allergic inflammation and T(H)1 /T(H)2 balance in airway allergic disease.
- Author
-
Zhang S, Shen Z, Hu G, Liu R, and Zhang X
- Subjects
- Animals, Bone Marrow drug effects, Bone Marrow pathology, Cell Count, Concanavalin A pharmacology, Corticosterone blood, Eosinophils pathology, Glucocorticoids antagonists & inhibitors, Immunization, Inflammation chemically induced, Inflammation pathology, Interferon-gamma metabolism, Interleukin-4 metabolism, Interleukin-5 metabolism, Leukocyte Count, Lung drug effects, Lung pathology, Lymphocyte Activation drug effects, Lymphocyte Activation immunology, Lymphocytes drug effects, Lymphocytes immunology, Lymphocytes metabolism, Male, Metyrapone administration & dosage, Metyrapone pharmacology, Mice, Mice, Inbred BALB C, Mifepristone administration & dosage, Mifepristone pharmacology, Ovalbumin administration & dosage, Ovalbumin immunology, Respiratory Hypersensitivity chemically induced, Respiratory Hypersensitivity pathology, Sneezing drug effects, Sneezing immunology, Specific Pathogen-Free Organisms, Spleen drug effects, Spleen pathology, Th1 Cells drug effects, Th1 Cells metabolism, Th1 Cells pathology, Th2 Cells drug effects, Th2 Cells metabolism, Th2 Cells pathology, Glucocorticoids immunology, Inflammation immunology, Respiratory Hypersensitivity immunology, Th1 Cells immunology, Th2 Cells immunology
- Abstract
Background: Glucocorticoids play an important role in modulating allergic inflammation and immune response. However, little is known about the role of endogenous glucocorticoids in airway allergic disease., Objective: To investigate the effects of endogenous glucocorticoids on regulating allergic inflammation and T(H)1/T(H)2 balance in an airway allergic murine model., Methods: An ovalbumin-sensitized murine model was established by intraperitoneal injection sensitization and intranasal challenge with ovalbumin. Glucocorticoid release was inhibited by administration of metyrapone, and the peripheral glucocorticoid receptors were blocked by administration of RU486. The numbers of eosinophils in the lung, peripheral blood, and bone marrow were quantified. The changes in T(H)2/T(H)1 cells were investigated by flow cytometry, and their cytokines were tested by enzyme-linked immunosorbent assay, including interleukin 4, interleukin 5, and interferon gamma, in the supernatant of the spleen cell culture., Results: Inhibition of endogenous glucocorticoids caused more sneezing and further increased eosinophil counts in the peripheral blood and bone marrow of the sensitized mice. However, by inhibition of endogenous glucocorticoids, the interferon gamma levels were upregulated, the interleukin 4 and 5 levels were down-regulated, and the ratio of T(H)2/T(H)1 cells decreased significantly, indicating a shift to a T(H)1-predominant immune response in sensitized mice., Conclusions: Our findings suggest that endogenous glucocorticoids play an important role in abating allergic inflammatory reaction and modulating the T(H)1/T(H)2 balance in an airway allergic murine model. Inhibition of endogenous glucocorticoids resulted in a shift to T(H)1 predominance, but that did not attenuate the severity of the allergic inflammatory reaction.
- Published
- 2009
- Full Text
- View/download PDF
13. Absence of nasal blockage in a Japanese cedar pollen-induced allergic rhinitis model mouse.
- Author
-
Ogita-Nakanishi H, Nabe T, Mizutani N, Fujii M, and Kohno S
- Subjects
- Airway Resistance immunology, Allergens immunology, Animals, Antigens, Plant immunology, Female, Immunoglobulin E blood, Immunoglobulin E immunology, Mice, Mice, Inbred Strains, Plant Extracts immunology, Plant Proteins immunology, Pollen chemistry, Pollen immunology, Sneezing immunology, Vaccination, Cryptomeria immunology, Disease Models, Animal, Nasal Obstruction immunology, Rhinitis, Allergic, Seasonal immunology
- Abstract
Background: Japanese cedar pollen-induced allergic rhinitis in a guinea pig model clearly induced not only sneezing but also biphasic nasal blockage. To date, there have only been a few reports on models of murine allergic rhinitis which clearly show nasal blockage. Therefore, in order to try and develop such a model, we administered multiple dosages of intranasal pollen or purified antigen protein Cry j 1., Methods: B10.S mice were sensitized by intranasal instillations of either pollen extract or Cry j 1 twice a day for 7 days, which was adsorbed on Al(OH)(3). Subsequently, once a week, the mice were given multiple intranasal instillation challenges of either the pollen suspension or Cry j 1 and the frequency of sneezing was observed after respective challenges were made. Specific airway resistance (sRaw) was measured as an indicator for nasal blockage. Cry j 1-specific IgE levels were measured using an enzyme-linked immunosorbent assay., Results: The serum Cry j 1-specific IgE level showed clear elevation only in the group sensitized by Cry j 1 + Al(OH)(3) and then challenged by Cry j 1. No elevations were seen in the groups sensitized by pollen extract + Al(OH)(3) followed by a pollen suspension challenge. There was an immediate increase in sneezing after challenges in all of the sensitized-challenged groups. Nevertheless, no increases in sRaw in any of the groups were detected at any of the time points during the 8 hours following the challenges., Conclusions: Cry j 1 may be more effective than crude antigens for efficient sensitization/challenge in mice. No increase in sRaw occurred, even in mice that possessed high amounts of Cry j 1-specific IgE and that exhibited sneezing.
- Published
- 2009
- Full Text
- View/download PDF
14. Clinical efficacy of halophilic lactic acid bacterium Tetragenococcus halophilus Th221 from soy sauce moromi for perennial allergic rhinitis.
- Author
-
Nishimura I, Igarashi T, Enomoto T, Dake Y, Okuno Y, and Obata A
- Subjects
- Adolescent, Adult, Antigens, Dermatophagoides immunology, Double-Blind Method, Dust immunology, Eosinophils cytology, Female, Humans, Immunoglobulin E blood, Immunoglobulin E immunology, Leukocyte Count, Male, Middle Aged, Nasal Mucosa immunology, Nasal Mucosa metabolism, Probiotics administration & dosage, Probiotics adverse effects, Quality of Life, Rhinitis, Allergic, Perennial diagnosis, Rhinitis, Allergic, Perennial immunology, Severity of Illness Index, Sneezing immunology, Treatment Outcome, Young Adult, Lactobacillaceae, Pediococcus, Probiotics therapeutic use, Rhinitis, Allergic, Perennial therapy, Soy Foods microbiology
- Abstract
Background: Recently, some common foods in daily life, especially lactic acid bacteria, have been found to have anti-allergic effects. We previously isolated a halophilic lactic acid bacterium, Tetragenococcus halophilus Th221, from soy sauce moromi, a mixture of koji and salt solution, and showed that it possesses an immunomodulatory activity that promotes T helper type 1 immunity., Methods: To evaluate the anti-allergic effects of Th221, we performed a randomized, double-blind, placebo-controlled study in 45 subjects with perennial allergic rhinitis (PAR) treated by oral administration of Th221 (high dose, 60 mg/day, 15 subjects; low dose, 20.4 mg/day, 15 subjects) or a placebo (15 subjects) for 8 weeks., Results: There were no significant differences among the groups that ingested Th221 and the placebo group regarding the disease severities, total nasal symptom scores and total nasal sign scores examined by physicians. However, the disease severity examined by physicians significantly improved in the high-dose group at the end of the trial compared with the beginning (p < 0.05). The total score for nasal symptoms of subjects who received a high dose of Th221 also showed a significant improvement at the end of the trial compared with the beginning (p < 0.01). According to the subjects' diaries, significant improvements in sneezing and rhinorrhea were observed during some periods in the high-dose group. The change in serum total immunoglobulin E improved significantly at the end of the trial compared with the beginning in this group (p < 0.05). The safety of Th221 treatment was confirmed by laboratory tests and inspection of the general condition of each subject., Conclusions: Th221 can be expected to safely improve the symptoms of PAR.
- Published
- 2009
- Full Text
- View/download PDF
15. Effect of Brazilian propolis on sneezing and nasal rubbing in experimental allergic rhinitis of mice.
- Author
-
Shinmei Y, Yano H, Kagawa Y, Izawa K, Akagi M, Inoue T, and Kamei C
- Subjects
- Allergens immunology, Animals, Brazil, Histamine administration & dosage, Histamine immunology, Immunoglobulin E biosynthesis, Male, Mice, Mice, Inbred BALB C, Propolis pharmacology, Pruritus immunology, Rats, Rhinitis, Allergic, Perennial immunology, Sneezing immunology, Allergens administration & dosage, Nose drug effects, Nose immunology, Propolis therapeutic use, Pruritus prevention & control, Rhinitis, Allergic, Perennial prevention & control, Sneezing drug effects
- Abstract
We studied the effect of Brazilian propolis on sneezing and nasal rubbing in experimental allergic rhinitis of mice. A single administration of propolis caused no significant effect on both antigen-induced nasal rubbing and sneezing at a dose of 1000 mg/kg, but a significant inhibition was observed after repeated administration for 2 weeks at this dose. Propolis caused no significant inhibitory effect on the production of total IgE level after repeated administration of 1000 mg/kg. The drug also caused no significant inhibition of histamine-induced nasal rubbing and sneezing at a dose of 1000 mg/kg. On the other hand, propolis significantly inhibited histamine release from rat mast cells induced by antigen and compound 48/80 at a concentration of more than 10 microg/ml. These results clearly demonstrated that propolis may be effective in the relief of symptoms of allergic rhinitis through inhibition of histamine release.
- Published
- 2009
- Full Text
- View/download PDF
16. A clinical study of Japanese cedar (Cryptomeria japonica) pollen-induced asthma.
- Author
-
Maeda Y, Akiyama K, and Shida T
- Subjects
- Adult, Antigens, Plant immunology, Asthma complications, Asthma physiopathology, Bronchial Provocation Tests, Cryptomeria immunology, Female, Humans, Injections, Intradermal, Male, Middle Aged, Plant Extracts immunology, Pollen immunology, Respiratory Sounds drug effects, Respiratory Sounds immunology, Rhinitis, Allergic, Seasonal complications, Rhinitis, Allergic, Seasonal physiopathology, Seasons, Skin Tests, Sneezing drug effects, Sneezing immunology, Antigens, Plant administration & dosage, Asthma immunology, Plant Extracts administration & dosage, Rhinitis, Allergic, Seasonal immunology
- Abstract
Background: Grass and birch pollens are known to induce asthma. However there are few reports about other pollen-induced asthma. Japanese cedar is the most common allergen in rhinitis in Japan but is controversial on whether it can provoke asthma., Methods: To clarify Japanese cedar pollen-induced asthma, we studied adult patients who were sensitized only to the Japanese cedar (CAP-RAST > = 2) and had symptoms of asthma during the cedar season. We defined cedar asthma as a patient who satisfied the 2 criteria mentioned above., Results: We found 6 adult asthma patients who fulfilled the two criteria. Five patients suffered from cedar pollinosis in addition to asthma, and 1 patient had no pollinosis. The cedar pollinosis preceded asthma in 3 cases and occurred at almost the same time in the other 2 cases. Pulmonary function was normal in these cases (FEV 1%, mean +/- SD, 76.5 +/- 10%), with a high threshold value in the non-specific airway hypersensitivity test (Ach-PC20, 2,696 to 20,000 microg/ml, 9294 +/- 2) and low total IgE (101 +/- 86 IU/ml). In the allergen provocation test, 3 subjects showed both an immediate and late asthmatic reaction., Conclusions: We concluded that Japanese cedar pollen could provoke not only pollinosis but also asthma in adults.
- Published
- 2008
- Full Text
- View/download PDF
17. Validation of guinea pig model of allergic rhinitis by oral and topical drugs.
- Author
-
Bahekar PC, Shah JH, Ayer UB, Mandhane SN, and Thennati R
- Subjects
- Administration, Oral, Administration, Topical, Animals, Female, Humidity, Immunoglobulin E blood, Immunoglobulin G analysis, Interleukin-4 analysis, Male, Ovalbumin pharmacology, Passive Cutaneous Anaphylaxis immunology, Sneezing drug effects, Sneezing immunology, Anti-Allergic Agents administration & dosage, Disease Models, Animal, Guinea Pigs, Rhinitis, Allergic, Perennial drug therapy, Rhinitis, Allergic, Perennial immunology, Rhinitis, Allergic, Perennial pathology
- Abstract
Ovalbumin-induced guinea pig model of rhinitis was assessed for its utility in the studies of rhinitis. Systemic sensitization and challenge with ovalbumin-induced rhinitis symptoms and an increase in anti-OVA-IgE and IgG titers, positive skin reactions and nasal lavage IL-4 concentration. Histopathology of nasal mucosa showed infiltration of eosinophils and other inflammatory cells consistent with the symptoms. Topical sensitization of ovalbumin yielded inconsistent symptoms of rhinitis. In systemic sensitization model, repeated challenge of ovalbumin caused similar response for at least 3 consecutive challenges. The symptoms were affected by relative humidity in the air and dosing volume of topical drugs. Sneezing and lacrimation were reduced by acute oral administration of the H1 receptor antagonists and steroids or the prophylactic oral administration of cysteinyl leukotriene (CysLT1) receptor antagonist montelukast or acute topical antihistamines, mast cell stabilizer sodium cromoglycate and anticholinergic agent ipratropium bromide, but not by a topical steroid. Nose rubbing was reduced significantly by some oral and topical antihistamines. Oral steroids offered excellent protection against all symptoms. Dexamethasone and montelukast also inhibited nasal lavage IL-4 concentration and inflammatory cell infiltration. Treatment with topical steroid fluticasone for 2 weeks had no effect on sneezing or rubbing. However, it caused complete inhibition of congestion. The cyclooxygenase inhibitor indomethacin had no effect on symptoms of rhinitis. The adrenergic alpha receptor agonist-decongestant oxymetazoline caused reduction in congestion. These results suggest that differential responsiveness to symptoms of rhinitis by a new agent can be very well profiled in the model in congruence with the mediation pathways and mechanism of action of drugs. The model provides complete symptomatic characterization of rhinitis and is a good tool for its study.
- Published
- 2008
- Full Text
- View/download PDF
18. Immunological and metabolic effects of cis-9, trans-11-conjugated linoleic acid in subjects with birch pollen allergy.
- Author
-
Turpeinen AM, Ylönen N, von Willebrand E, Basu S, and Aro A
- Subjects
- Adult, Blood Cell Count, Blood Glucose metabolism, Cells, Cultured, Cytokines biosynthesis, Female, Humans, Immunoglobulins blood, Inflammation Mediators metabolism, Linoleic Acids, Conjugated immunology, Lipid Peroxidation drug effects, Lipids blood, Lymphocyte Subsets drug effects, Lymphocyte Subsets immunology, Male, Middle Aged, Patient Compliance, Rhinitis, Allergic, Seasonal blood, Rhinitis, Allergic, Seasonal immunology, Severity of Illness Index, Sneezing immunology, Young Adult, Betula immunology, Dietary Supplements, Linoleic Acids, Conjugated therapeutic use, Pollen immunology, Rhinitis, Allergic, Seasonal prevention & control
- Abstract
Animal studies suggest that conjugated linoleic acid (CLA) may modulate the immune response, while studies in healthy human subjects have shown little effect and results are controversial. However, the effects of CLA may be more prominent in situations of immune imbalance, such as allergy. We studied the effects of the natural CLA isomer, cis-9, trans-11-CLA, on allergy symptoms and immunological parameters in subjects with birch pollen allergy. In a randomised, placebo-controlled study, forty subjects (20-46 years) with diagnosed birch pollen allergy received 2 g CLA/d in capsules, which contained 65.3 % cis-9, trans-11-CLA and 8.5 % trans-10, cis-12-CLA (n 20), or placebo (high-oleic acid sunflower-seed oil) (n 20) for 12 weeks. The supplementation began 8 weeks before the birch pollen season and continued throughout the season. Allergy symptoms and use of medication were recorded daily. Lymphocyte subsets, cytokine production, immunoglobulins, C-reactive protein, lipid and glucose metabolism and lipid peroxidation were assessed before and after supplementation. The CLA group reported a better overall feeling of wellbeing (P < 0.05) and less sneezing (P < 0.05) during the pollen season. CLA supplementation decreased the in vitro production of TNF-alpha (P < 0.01), interferon-gamma (P < 0.05) and IL-5 (P < 0.05). Total plasma IgE and birch-specific IgE concentrations did not differ between groups, whereas plasma IgA (P < 0.05), granulocyte macrophage colony-stimulating factor (P < 0.05) and eosinophil-derived neurotoxin (P < 0.05) concentrations were lower after CLA supplementation. Urinary excretion of 8-iso-PGF2alpha, a major F2-isoprostane (P < 0.01), and 15-keto-dihydro-PGF2alpha, a primary PGF2alpha metabolite (P < 0.05), increased in the CLA group. The results suggest that cis-9, trans-11-CLA has modest anti-inflammatory effects in allergic subjects.
- Published
- 2008
- Full Text
- View/download PDF
19. Differential responses to various classes of drugs in a model of allergic rhinitis in guinea pigs.
- Author
-
Al Suleimani YM, Dong Y, and Walker MJ
- Subjects
- Acetates administration & dosage, Acetates therapeutic use, Acute Disease, Animals, Cetirizine administration & dosage, Cetirizine therapeutic use, Cyclopropanes, Dexamethasone administration & dosage, Dexamethasone therapeutic use, Disease Models, Animal, Guinea Pigs, Heparin administration & dosage, Heparin therapeutic use, Histamine H1 Antagonists administration & dosage, Histamine H1 Antagonists therapeutic use, Male, NG-Nitroarginine Methyl Ester administration & dosage, NG-Nitroarginine Methyl Ester therapeutic use, Nasal Obstruction drug therapy, Nasal Obstruction etiology, Nasal Obstruction immunology, Ovalbumin immunology, Pyrilamine administration & dosage, Pyrilamine therapeutic use, Quinolines administration & dosage, Quinolines therapeutic use, Rhinitis, Allergic, Seasonal immunology, Rhinitis, Allergic, Seasonal physiopathology, Sneezing drug effects, Sneezing immunology, Sulfides, Rhinitis, Allergic, Seasonal drug therapy
- Abstract
Different drugs from various pharmacological classes were compared for their ability to protect against the nasal effects of acute allergen challenge in a guinea pig model. In the model, sneezing and nose rubbing were recorded after an initial allergen challenge in guinea pigs previously sensitized to egg albumin. Four days later the same guinea pigs were re-challenged a second time when anesthetised. In these anaesthetized animals, nasal airway pressure, pulmonary inflation pressure and cellular infiltration into nasal lavage fluid were measured. The drug tested were autacoid antagonists (mepyramine--3mg/kg, cetirizine--3mg/kg and montelukast--10mg/kg), L-NAME (10 or 20mg/kg), heparin (20mg/kg) and dexamethasone (20mg/kg) given either intraperitoneally or intravenously; all were given shortly before challenge. Sneezing induced by allergen challenge was statistically significantly reduced by mepyramine, cetirizine and dexamethasone whereas only cetirizine reduced nose rubbing. Changes in nasal airway pressure due to allergen exposure were reduced by cetirizine, montelukast, L-NAME, and heparin, but not by mepyramine, nor dexamethasone. In the presence of L-NAME, nasal airway pressure actually changed in the opposite direction. Cellular infiltration, as assessed by cytometry in nasal lavage fluid 60min after acute allergen challenge, was reduced by montelukast and heparin but not by antihistamines, L-NAME nor dexamethasone. This pattern of effects of the drugs, given by doses and routes previously described in the literature as being effective was not completely consistent with expected responses. The lack of effect of dexamethasone probably reflects the fact that it was given acutely whereas in the clinic chronic administration is used. The two antihistamines were not identical in their actions, presumably reflecting the fact that cetirizine has therapeutic actions not entirely confined to blockade of H1 receptors. Montelukast has not been reported to have major effects on sneezing and itching in the clinic but reduces nasal obstruction (lower nasal airway pressure or nasal patency). Montelukast's effects on cellular infiltration indicate the possible involvement of leukotrienes. Heparin has actions on inflammatory cell infiltration. This could explain its profile of reducing both cellular infiltration, and increased nasal airway pressure.
- Published
- 2008
- Full Text
- View/download PDF
20. A comprehensive model of allergic rhinitis in guinea pigs.
- Author
-
Al Suleimani M, Ying D, and Walker MJ
- Subjects
- Animals, Blood Pressure, Guinea Pigs, Inhalation Exposure, Lung Compliance immunology, Male, Nasal Cavity drug effects, Nasal Cavity immunology, Nasal Obstruction etiology, Ovalbumin administration & dosage, Ovalbumin adverse effects, Ovalbumin immunology, Pressure, Rhinitis, Allergic, Seasonal complications, Sneezing immunology, Disease Models, Animal, Nasal Cavity physiopathology, Nasal Obstruction physiopathology, Rhinitis, Allergic, Seasonal physiopathology
- Abstract
Introduction: The economic and social impact of allergic rhinitis is substantial. The effectiveness of currently available medications is limited and therefore investigations for more effective drugs is essential. This study was intended to establish a model of allergic rhinitis in guinea pigs that can be utilized for further investigation of new drugs., Methods: Male Dunkin Hartley guinea pigs were sensitized intranasally to, and challenged with, ovalbumin. Sneezing (SN) and nose rubbing (NR) response to allergen challenge were observed on day 21 post-initiation of sensitization in conscious guinea pigs. Nasal blockade (NB), leukocyte infiltration, and lung inflation pressure (LIP) were assessed in the same guinea pigs 23-28 days post-initiation of sensitization. A ventilator/flow method was used to measure NB and LIP. Leukocyte infiltration into nasal lavage fluid 60 min after challenge in the same animals was recorded as total and differential cell counts., Results: Sensitized guinea pigs produced acute allergic responses after allergen challenge. This was characterized by increases in SN, NR, NB, and eosinophil infiltration. In addition, intranasal allergen challenge did not change lung inflation pressure., Discussion: Allergen-induced rhinitis in guinea pigs resembles that in humans. The model reported in this study can be used to reflect the effectiveness of drugs currently used to treat allergic rhinitis and to investigate new potential drugs for the treatment of allergic rhinitis.
- Published
- 2007
- Full Text
- View/download PDF
21. Mechanisms of symptoms of the common cold and influenza.
- Author
-
Eccles R
- Subjects
- Anorexia etiology, Common Cold complications, Common Cold immunology, Cough etiology, Diagnosis, Differential, Fever etiology, Headache etiology, Humans, Influenza, Human complications, Influenza, Human immunology, Sneezing immunology, Common Cold diagnosis, Influenza, Human diagnosis
- Published
- 2007
- Full Text
- View/download PDF
22. Interactive effect of histamine and prostaglandin D2 on nasal allergic symptoms in rats.
- Author
-
Rahman A, Inoue T, Ago J, Ishikawa T, and Kamei C
- Subjects
- Administration, Intranasal, Administration, Oral, Animals, Carbazoles administration & dosage, Carbazoles pharmacology, Chlorpheniramine administration & dosage, Chlorpheniramine pharmacology, Cyproheptadine administration & dosage, Cyproheptadine pharmacology, Dose-Response Relationship, Drug, Drug Synergism, Histamine immunology, Histamine Agents administration & dosage, Histamine Agents immunology, Histamine H1 Antagonists administration & dosage, Histamine H1 Antagonists pharmacology, Hydantoins administration & dosage, Hydantoins pharmacology, Injections, Intravenous, Nasal Mucosa immunology, Nasal Mucosa pathology, Prostaglandin D2 immunology, Rats, Rats, Wistar, Receptors, Immunologic antagonists & inhibitors, Receptors, Prostaglandin antagonists & inhibitors, Rhinitis chemically induced, Rhinitis prevention & control, Sneezing immunology, Sulfonamides administration & dosage, Sulfonamides pharmacology, Histamine administration & dosage, Nasal Mucosa drug effects, Prostaglandin D2 administration & dosage, Sneezing drug effects
- Abstract
This study was undertaken to investigate the interactive effect of histamine and prostaglandin D(2) in nasal allergic symptoms in rats. The intranasal application of histamine at doses lower than 10 mumol/site caused no sneezing or nasal rubbing. In addition, prostaglandin D(2) also showed no significant increase in these responses, even at a dose of 10 nmol/site. On the other hand, the simultaneous instillation of histamine and prostaglandin D(2) resulted in a 1000 times more potent effect in inducing nasal symptoms than the administration of histamine alone. Thus, prostaglandin D(2) enhanced the actions of histamine in inducing sneezing and nasal rubbing in a dose-dependent manner, and significant effects were observed at doses higher than 1 nmol/site. The responses induced by the simultaneous application of histamine and prostaglandin D(2) were inhibited by chlorpheniramine, cyproheptadine, BW A868C and ramatroban. Chlorpheniramine and cyproheptadine showed the dose-related inhibition of nasal symptoms induced by the combined administration of histamine (10 nmol) and prostaglandin D(2) (10 nmol), but the effect of cyproheptadine was relatively weak compared with chlorpheniramine. Moreover, BW A868C and ramatroban also showed the inhibition of nasal symptoms induced by the simultaneous administration of histamine and prostaglandin D(2) in a dose-dependent manner. BW A868C was more potent in inhibiting the nasal symptoms than ramatroban. These results clearly indicate that prostaglandin D(2) showed a synergistic effect on sneezing and nasal rubbing induced by histamine in rats, and its effect occurred through both prostaglandin D(2) and CRTH2 (chemoattractant receptor-homologous molecule expressed on TH2 cells) receptors.
- Published
- 2007
- Full Text
- View/download PDF
23. Early and late allergic phase related cough response in sensitized guinea pigs with experimental allergic rhinitis.
- Author
-
Brozmanová M, Calkovský V, Plevková J, Bartos V, Plank L, and Tatár M
- Subjects
- Allergens immunology, Animals, Citric Acid administration & dosage, Cough chemically induced, Cough physiopathology, Disease Models, Animal, Guinea Pigs, Male, Nasal Provocation Tests, Ovalbumin immunology, Respiratory System immunology, Respiratory System pathology, Respiratory System physiopathology, Rhinitis, Allergic, Perennial pathology, Rhinitis, Allergic, Perennial physiopathology, Sneezing immunology, Time Factors, Cough immunology, Immunization, Rhinitis, Allergic, Perennial immunology
- Abstract
Cough is a common and important symptom of asthma and allergic rhinitis. Previous experimental evidence has shown enhanced cough sensitivity during early phase of experimental allergic rhinitis in guinea pigs. We hypothesized that airway inflammation during the late phase response after repeated nasal antigen challenge may affect the afferent sensory nerve endings in the larynx and tracheobronchial tree and may also modulate cough response. In the present study we evaluated the cough sensitivity during a period of early and late allergic response in sensitized guinea pigs after repeated nasal antigen challenges. Forty-five guinea pigs were sensitized with ovalbumin (OVA). Four weeks later 0.015 ml of 0.5 % OVA was intranasally instilled to develop a model of allergic rhinitis that was evaluated from the occurrence of typical clinical symptoms. Animals were repeatedly intranasally challenged either by OVA (experimental group) or by saline (controls) in 7-day intervals for nine weeks. Cough was elicited by inhalation of citric acid aerosols. Cough was evaluated at 1 or 3 h after the 6th nasal challenge and 17 or 24 h after the 9th nasal challenge. The cough reflex was significantly increased at 1 and 3 h after repeated nasal challenge in contrast to cough responses evoked at 17 and 24 h after repeated nasal challenge. In conclusion, enhanced cough sensitivity only corresponds to an early allergic response after repeated nasal challenges.
- Published
- 2006
- Full Text
- View/download PDF
24. Efficacy of Tinospora cordifolia in allergic rhinitis.
- Author
-
Badar VA, Thawani VR, Wakode PT, Shrivastava MP, Gharpure KJ, Hingorani LL, and Khiyani RM
- Subjects
- Administration, Oral, Adolescent, Adult, Double-Blind Method, Eosinophils immunology, Female, Goblet Cells immunology, Humans, Male, Middle Aged, Nasal Obstruction drug therapy, Nasal Obstruction immunology, Neutrophils immunology, Sneezing drug effects, Sneezing immunology, Rhinitis, Allergic, Perennial drug therapy, Rhinitis, Allergic, Seasonal drug therapy, Tinospora
- Abstract
The efficacy of Tinospora cordifolia (TC) extract in patients of allergic rhinitis was assessed in a randomized double blind placebo controlled trial. Seventy-five patients were randomly given either TC or placebo for 8 weeks. They were clinically examined and Hb %, TLC, DLC and nasal smear was done. At the end of trial baseline investigations were repeated, drug decoded and results analyzed. With TC treatment 100% relief was reported from sneezing in 83% patients, in 69% from nasal discharge, in 61% from nasal obstruction and in 71% from nasal pruritus. In placebo group, there was no relief in 79% from sneezing, in 84.8% from nasal discharge, in 83% from nasal obstruction, and in 88% from nasal pruritus. The difference between TC and placebo groups was highly significant. TLC increased in 69% patients in drug treated group and in only 11% with placebo. After TC, eosinophil and neutrophil count decreased and goblet cells were absent in nasal smear. After placebo, decrease in eosinophil and neutrophil count was marginal and goblet cells were present. TC significantly decreased all symptoms of allergic rhinitis. Nasal smear cytology and leukocyte count correlated with clinical findings. TC was well tolerated.
- Published
- 2005
- Full Text
- View/download PDF
25. Acquired nasal hyperresponsiveness aggravates antigen-induced rhinitis in the guinea pig.
- Author
-
Mizutani N, Nabe T, Takenaka H, and Kohno S
- Subjects
- Animals, Antigens administration & dosage, Chromones pharmacology, Disease Models, Animal, Guinea Pigs, Histamine H1 Antagonists pharmacology, Leukotriene Antagonists pharmacology, Male, Nasal Cavity drug effects, Nasal Cavity physiopathology, Nasal Obstruction drug therapy, Nasal Obstruction immunology, Nasal Obstruction physiopathology, Pollen immunology, Pyrilamine pharmacology, Rhinitis, Allergic, Seasonal drug therapy, Sneezing drug effects, Sneezing immunology, Time Factors, Antigens immunology, Nasal Cavity immunology, Rhinitis, Allergic, Seasonal immunology
- Abstract
Whether a state of nasal hyperresponsiveness influences antigen-induced biphasic nasal blockage and sneezing were examined using a guinea pig model of allergic rhinitis. Sensitized animals were challenged with an antigen, Japanese cedar pollen, once every week. Before the 13th challenge, the animals were randomly divided into 2 groups, and then the 13th challenge was performed (Groups A-0 and B-0). The 14th challenge was done on day 2 (Group A-2) and on day 7 (Group B-7) after the 13th challenge, on which nasal hyperresponsiveness was present and absent, respectively. Biphasic nasal blockage and sneezing after the challenge in Group A-2 were more severe than those in Group A-0, while those of Group B-7 were almost the same as those of Group B-0. An anti-histaminic, mepyramine, inhibited sneezing but not the biphasic nasal blockage in Group B-7. A cysteinyl leukotriene (CysLT) antagonist, pranlukast, suppressed the late nasal blockage but not the early blockage and sneezing in Group B-7. In contrast, in Group A-2, mepyramine significantly attenuated not only sneezing but also the early nasal blockage. Pranlukast significantly inhibited both nasal blockage and sneezing in Group A-2. In conclusion, nasal hyperresponsiveness aggravated the antigen-induced nasal responses, to which histamine and CysLTs considerably contributed.
- Published
- 2003
- Full Text
- View/download PDF
26. Effects of TAK-427 on acute nasal symptoms and nasal obstruction in guinea pig model of experimental allergic rhinitis.
- Author
-
Fukuda S, Midoro K, Gyoten M, Kawano Y, Ashida Y, Nabe T, Kohno S, and Nagaya H
- Subjects
- Acute Disease, Animals, Anti-Inflammatory Agents pharmacology, Disease Models, Animal, Guinea Pigs, Histamine metabolism, Male, Nasal Obstruction immunology, Ovalbumin immunology, Pollen immunology, Rhinitis, Allergic, Perennial immunology, Rhinitis, Allergic, Perennial physiopathology, Rhinitis, Allergic, Seasonal immunology, Rhinitis, Allergic, Seasonal physiopathology, Sneezing drug effects, Sneezing immunology, Histamine H1 Antagonists pharmacology, Imidazoles pharmacology, Nasal Obstruction drug therapy, Pyridazines pharmacology, Rhinitis, Allergic, Perennial drug therapy, Rhinitis, Allergic, Seasonal drug therapy
- Abstract
TAK-427 (2-[6-[[3-[4-(diphenylmethoxy)piperidino]propyl]amino]imidazo[1,2-b]pyridazin-2-yl]-2-methylpropionic acid dihydrate) is a novel anti-allergic agent that has both histamine H1-receptor antagonist and anti-inflammatory activities. In this study, we evaluated the efficacy of TAK-427 on acute nasal responses and nasal obstruction using various guinea pig models of allergic rhinitis. TAK-427 inhibited the histamine-induced nasal reactions with an ID50 value of 0.633 mg/kg, p.o. TAK-427 (0.1-10 mg/kg, p.o.) and most histamine H1-receptor antagonists tested inhibited the increase in intranasal pressure, nasal hypersecretion, sneezing and nasal itching caused by a single antigen challenge in sensitized guinea pigs. In addition, TAK-427 (0.3, 30 mg/kg, p.o.) significantly inhibited the development of nasal obstruction when sensitized guinea pigs were repeatedly challenged via inhalation with Japanese cedar pollen, whereas the histamine H1-receptor antagonist, azelastine (1 mg/kg, p.o.), and ketotifen (1 mg/kg, p.o.) were without effect. These results suggest that TAK-427 might not only suppress acute nasal symptoms but also ameliorate nasal obstruction via the effects other than those as a histamine H1-receptor antagonist.
- Published
- 2003
- Full Text
- View/download PDF
27. Symptom severity assessment of allergic rhinitis: part 1.
- Author
-
Spector SL, Nicklas RA, Chapman JA, Bernstein IL, Berger WE, Blessing-Moore J, Dykewicz MS, Fineman SM, Lee RE, Li JT, Portnoy JM, Schuller DE, Lang D, and Tilles SA
- Subjects
- Humans, Nasal Mucosa immunology, Quality of Life, Rhinitis, Allergic, Perennial immunology, Sneezing immunology, Rhinitis, Allergic, Perennial diagnosis, Severity of Illness Index
- Published
- 2003
- Full Text
- View/download PDF
28. Histamine H1 receptors are involved in mouse nasal allergic responses: a demonstration with H1 receptor-deficient mice.
- Author
-
Kayasuga R, Sugimoto Y, Watanabe T, and Kamei C
- Subjects
- Animals, Dose-Response Relationship, Drug, Histamine administration & dosage, Histamine Agonists pharmacology, Histamine Antagonists pharmacology, Male, Mice, Mice, Inbred C57BL, Mice, Mutant Strains, Nasal Mucosa drug effects, Nasal Mucosa immunology, Nasal Mucosa metabolism, Receptors, Histamine H1 genetics, Respiratory Hypersensitivity etiology, Respiratory Hypersensitivity genetics, Sneezing drug effects, Sneezing genetics, Sneezing immunology, Receptors, Histamine H1 deficiency, Receptors, Histamine H1 physiology, Respiratory Hypersensitivity metabolism
- Abstract
The role of histamine H1 receptors in nasal allergic symptoms (sneezing and nasal rubbing) were studied using histamine H1 receptor-deficient mice. Intranasal instillation of histamine solution resulted in significant increases in sneezing and nasal rubbing in wild-type mice, whereas no increases were observed in histamine H1 receptor-deficient mice. The histamine H1 receptor agonist 2-pyridylethylamine induced sneezing and nasal rubbing in a dose-dependent-manner in wild-type mice, but no such increase was found in histamine H1 receptor-deficient mice. On the other hand, the histamine H2 receptor agonist dimaprit did not increase sneezing and nasal rubbing in wild-type mice. Histamine H1 receptor antagonists such as chlorpheniramine and epinastine significantly inhibited nasal allergic symptoms caused by histamine, but the histamine H2 receptor antagonists cimetidine and famotidine showed no effect. No additional effects were observed by combined use of chlorpheniramine and cimetidine or famotidine compared with cimetidine or famotidine alone. These results suggested that histamine H1 receptors play an important role in nasal allergy symptoms induced by histamine.
- Published
- 2002
- Full Text
- View/download PDF
29. Comparison of five new antihistamines (H1-receptor antagonists) in patients with allergic rhinitis using nasal provocation studies and skin tests.
- Author
-
van Steekelenburg J, Clement PA, and Beel MH
- Subjects
- Allergens administration & dosage, Allergens adverse effects, Allergens immunology, Eosinophilia chemically induced, Eosinophilia immunology, Histamine H1 Antagonists immunology, Humans, Poaceae adverse effects, Poaceae immunology, Pollen adverse effects, Pollen immunology, Random Allocation, Rhinitis, Allergic, Perennial complications, Rhinitis, Allergic, Perennial immunology, Sneezing immunology, Treatment Outcome, Histamine H1 Antagonists administration & dosage, Nasal Provocation Tests, Rhinitis, Allergic, Perennial drug therapy, Skin Tests
- Abstract
Background: It was the aim of the authors to compare all of the latest second-generation antihistamines and to see if there were significant differences in their efficacy. It is important for ENT specialists to know if these differences exist, as it is for general practitioners trying to choose between these drugs., Methods: In 12 confirmed grass pollen allergic patients the authors performed nasal smears to asses eosinophilia, histamine/grass pollen skin tests, and grass pollen nasal provocation tests. All tests were performed before and after administration of one of five different antihistamines (cetirizine, loratadine, ebastine, fexofenadine, mizolastine) or placebo. The order of administration of antihistamines and placebo was randomised, and patients were not aware of which drug they were given. A decrease in nasal eosinophilia (nasal smear), or nasal or skin reactivity (provocation tests) was looked for., Results: A significant decrease in nasal eosinophilia was observed for all antihistamines but not for placebo. For the grass pollen nasal provocation tests, the decrease was significant for nasal blockage and sneezing; for rhinorrhea there was an insignificant decrease that was true for all antihistamines. A significant reduction in histamine/grass pollen skin test reactivity was also observed for all antihistamines, during an 8 h observation period. A significant difference in efficacy between the different antihistamines could not be found with any of the tests performed., Conclusions: For the newer nonsedating H1-antagonists there appears to be no clinically relevant differences in activities--at least not in our study. Preference of the patient may be the most important factor in making a choice between these drugs.
- Published
- 2002
- Full Text
- View/download PDF
30. No involvement of interleukin-5 or eosinophils in experimental allergic rhinitis in guinea pigs.
- Author
-
Yamasaki M, Mizutani N, Sasaki K, Nabe T, and Kohno S
- Subjects
- Animals, Antibodies, Monoclonal pharmacology, Bone Marrow Cells cytology, Bone Marrow Cells drug effects, Bone Marrow Cells immunology, Cell Degranulation, Cysteine analysis, Eosinophils cytology, Eosinophils drug effects, Goblet Cells immunology, Goblet Cells physiology, Guinea Pigs, Histamine immunology, Leukocytes cytology, Leukocytes drug effects, Leukocytes immunology, Leukotrienes analysis, Male, Nasal Lavage Fluid chemistry, Nasal Lavage Fluid cytology, Nasal Mucosa drug effects, Nasal Mucosa immunology, Nasal Mucosa pathology, Nasal Obstruction immunology, Nasal Provocation Tests, Rhinitis blood, Rhinitis pathology, Sneezing immunology, Thromboxane B2 analysis, Eosinophils immunology, Interleukin-5 immunology, Rhinitis immunology
- Abstract
The aim of this study is to evaluate whether nasal airway eosinophilia is a true pathogenetic component of allergic rhinitis. We investigated the effects of TRFK5, an anti-interleukin-5 antibody, not only on leukocyte mobilization from the bone marrow, but also on the development of nasal symptoms and hyperresponsiveness in a guinea pig model of allergic rhinitis. Intranasally sensitized animals were repetitively challenged by exposure to Japanese cedar pollen as antigen. TRFK5 (100 microg/kg, i.p.) given 12 h before the final antigen challenge selectively prevented the antigen-induced eosinophilia in blood and the nasal airway, and suppressed the corresponding decrease in the number of cells in bone marrow; however, it failed to inhibit the immediate development of sneezing, early and late nasal blockage responses, goblet cell degranulation and nasal hyperresponsiveness to histamine. Furthermore, TRFK5 did not significantly affect the production of thromboxane A(2) and cysteinyl leukotrienes in the nasal airway during the late response. These results strongly suggest that while interleukin-5 is essential for eosinophil migration from the bone marrow to the nasal airway, neither interleukin-5 nor eosinophils are required for the development of the nasal symptoms and nasal hyperresponsiveness of allergic rhinitis.
- Published
- 2002
- Full Text
- View/download PDF
31. Exposure to ozone aggravates nasal allergy-like symptoms in guinea pigs.
- Author
-
Iijima MK, Kobayashi T, Kamada H, and Shimojo N
- Subjects
- Administration, Intranasal, Animals, Antibody Specificity, Eosinophils immunology, Guinea Pigs, Immunoglobulin E biosynthesis, Immunoglobulin E immunology, Immunoglobulin G biosynthesis, Immunoglobulin G immunology, Male, Nasal Mucosa drug effects, Nasal Mucosa immunology, Nasal Mucosa metabolism, Ovalbumin administration & dosage, Ovalbumin immunology, Ozone immunology, Rhinitis, Allergic, Perennial chemically induced, Rhinitis, Allergic, Perennial immunology, Sneezing drug effects, Sneezing immunology, Ozone adverse effects, Rhinitis, Allergic, Perennial etiology
- Abstract
The ability of O3 exposure to aggravate ovalbumin (OVA)-induced nasal allergy-like symptoms was studied in guinea pigs. Guinea pigs were exposed to filtered air or to 0.4 ppm O3 for 5 weeks. During the exposure, 1% OVA or saline was administered into the nasal cavities once a week. Sneezes and nasal secretions were measured for a 20-min period following OVA administration. The number of eosinophils infiltrating both nasal epithelium and subepithelium and titers of specific anti-OVA-IgG were measured 24 h after the last administration. Ozone increased OVA-induced sneezing and nasal secretion, as well as induced nasal hyper-responsiveness to physical stimuli. The number of eosinophils infiltrating the nasal subepithelium was increased by O3, and the titer of anti-OVA-IgG tended to increase in the O3-exposed animals. Thus, exposure to O3 aggravated nasal allergy-like symptoms by inducing nasal hyper-responsiveness, the infiltration of eosinophils, and by tending to increase the production of anti-OVA-IgG.
- Published
- 2001
- Full Text
- View/download PDF
32. Complement activation in the nasal mucosa following nasal ragweed-allergen challenge.
- Author
-
Mezei G, Varga L, Veres A, Füst G, and Cserháti E
- Subjects
- Blood Proteins drug effects, Blood Proteins metabolism, Eosinophil Granule Proteins, Eosinophils immunology, Eosinophils metabolism, Female, Humans, Male, Nasal Lavage Fluid chemistry, Nasal Lavage Fluid immunology, Nasal Provocation Tests, Neutrophils metabolism, Sneezing drug effects, Sneezing immunology, Allergens immunology, Complement Activation, Hypersensitivity immunology, Nasal Mucosa immunology, Neutrophils immunology, Ribonucleases
- Abstract
The aim of this study was to explore complement activation in the nasal lavage following a nasal ragweed-allergen challenge. The study was carried out with 15 adolescents who were allergic to ragweed and with six non-allergic healthy volunteers. Following the baseline measurement after the symptoms were registered, subjects were given increasing doses of ragweed allergen. Lavage fluid was collected and tested for a complement-activation product (C3bBbP). The allergic patients responded to allergen provocation with an increase in C3bBbP formation compared to the initial lavage (p = 0.001). The C3bBbP level remained low in the lavage fluids of the non-allergic controls. We found a strong correlation between the threshold dose that induced symptoms and the dose where the maximum complement activation was detected (r = 0.78, p = 0.001). Our findings indicate that in allergic patients nasal challenge with ragweed allergen induces a rise in complement activation in the nasal lavage fluid. These results highlight the role of the complement system in the allergic inflammation on the nasal mucosal surface.
- Published
- 2001
- Full Text
- View/download PDF
33. Comparison of cedar pollen-induced allergic rhinitis in passively and actively sensitized guinea pigs.
- Author
-
Nabe T, Mizutani N, Osaki S, Sugahara S, Takenaka H, and Kohno S
- Subjects
- Airway Resistance drug effects, Airway Resistance immunology, Animals, Guinea Pigs, Histamine metabolism, Histamine H1 Antagonists pharmacology, Histamine H1 Antagonists therapeutic use, Leukotriene D4 pharmacology, Male, Nasal Provocation Tests methods, Pyrilamine, Rhinitis, Allergic, Seasonal drug therapy, Rhinitis, Allergic, Seasonal physiopathology, Sneezing drug effects, Sneezing immunology, Trees immunology, Immunization, Passive methods, Pollen immunology, Rhinitis, Allergic, Seasonal immunology, Vaccination methods
- Abstract
We have developed an allergic rhinitis model in guinea pigs using Japanese cedar pollen as antigen. In the present study, we examined whether provocation by pollen induces similar magnitudes of rhinitis symptoms in passively and actively sensitized guinea pigs. One group of animals was actively sensitized by intranasal application of pollen extract, and another was passively sensitized by intraperitoneal injection with anti-pollen serum. Actively and passively sensitized groups were then challenged by repeated and a single pollen inhalation, respectively. In both groups, sneeze was induced immediately after the challenge. The actively sensitized animals developed not only early but also late nasal blockage, whereas the passively sensitized animals showed only early nasal blockage. In both groups, an H1 antagonist, mepyramine, inhibited the occurrence of sneezing but did not inhibit nasal blockage. Nasal hyperresponsiveness to intranasal instillation of leukotriene D4 was obvious only in the actively sensitized animals. We thus conclude that although early nasal blockage is induced by a single antigen-antibody reaction, repetitive anaphylactic reaction is required for occurrence of late nasal blockage and hyperresponsiveness to stimuli. Furthermore, histamine plays a central role in induction of sneezing but not in nasal blockage, irrespective of whether animals are actively or passively sensitized.
- Published
- 2001
- Full Text
- View/download PDF
34. Wheezing, sneezing, and cancer risk - still an open door.
- Author
-
Volkers N
- Subjects
- Asthma immunology, Case-Control Studies, Eczema immunology, Germany epidemiology, Glioma epidemiology, Glioma immunology, HIV Seropositivity epidemiology, HIV Seropositivity immunology, Humans, Hypersensitivity epidemiology, Lymphoma, Non-Hodgkin epidemiology, Lymphoma, Non-Hodgkin immunology, Respiratory Sounds immunology, Risk, San Francisco epidemiology, Sneezing immunology, Hypersensitivity immunology, Neoplasms epidemiology, Neoplasms immunology
- Published
- 1999
- Full Text
- View/download PDF
35. Pathophysiological features of the nasal mucosa in patients with idiopathic rhinitis compared to allergic rhinitis.
- Author
-
Numata T, Konno A, Hasegawa S, Hanazawa T, Nagata H, Motosugi H, and Terada N
- Subjects
- Adolescent, Adult, Age of Onset, Air, Blood Pressure, Cold Temperature, Eosinophils pathology, Epithelial Cells pathology, Female, Histamine pharmacology, Humans, Leukocyte Count, Male, Nasal Lavage Fluid chemistry, Nasal Mucosa metabolism, Nasal Mucosa pathology, Rhinitis, Allergic, Perennial metabolism, Rhinitis, Allergic, Perennial pathology, Rhinitis, Vasomotor metabolism, Rhinitis, Vasomotor pathology, Sneezing immunology, Nasal Mucosa physiopathology, Rhinitis, Allergic, Perennial physiopathology, Rhinitis, Vasomotor physiopathology
- Abstract
Background: The literature on abnormality of vasomotor responses of the nasal mucosa to cold stimulation of the skin in idiopathic rhinitis is conflicting. The objective of this study was to elucidate pathophysiological features of the nasal mucosa in idiopathic rhinitis compared to allergic rhinitis., Methods: The following were studied in patients with idiopathic rhinitis and allergic rhinitis and in normal controls: (1) threshold of the nasal reaction to histamine; (2) inflammatory cells in nasal lavage and scraped nasal mucosal epithelium, and (3) nasal vasomotor response to cold stimulation of the feet evaluated by acoustic rhinometry., Results: Inflammatory cells were not found to be involved in idiopathic rhinitis. Nasal reactivity to histamine was significantly enhanced in patients with idiopathic rhinitis compared to normal controls, but was significantly lower compared to those with allergic rhinitis. The most prominent finding in idiopathic rhinitis was nasal mucosal swelling induced by cold stimulation of the feet. While in normal controls, cold stimulation of the feet caused mucosal contraction due to sympathetic excitation, sympathetic nasal vasomotor response in idiopathic rhinitis patients was significantly inhibited and caused mucosal swelling and enhanced nasal secretion. Mucosal reactions observed in allergic rhinitis were between those observed in idiopathic rhinitis and in normal controls. Cold stimulation of the feet increased systolic blood pressure by 5-15 mm Hg, but the degree of increase observed in the 3 groups was almost equal., Conclusions: The above findings indicate that patients with idiopathic rhinitis have abnormalities that inhibit sympathetic reactions and enhance parasympathetic vasomotor response at peripheral levels, possibly in the nasal mucosa.
- Published
- 1999
- Full Text
- View/download PDF
36. Development of pollen-induced allergic rhinitis with early and late phase nasal blockage in guinea pigs.
- Author
-
Nabe T, Mizutani N, Shimizu K, Takenaka H, and Kohno S
- Subjects
- Aluminum Hydroxide immunology, Animals, Guinea Pigs, Immunoglobulin E biosynthesis, Immunoglobulin E immunology, Male, Nasal Obstruction physiopathology, Nasal Provocation Tests, Passive Cutaneous Anaphylaxis immunology, Respiratory Function Tests, Rhinitis, Allergic, Seasonal physiopathology, Sneezing immunology, Time Factors, Nasal Obstruction immunology, Pollen immunology, Rhinitis, Allergic, Seasonal immunology
- Abstract
Objective and Design: Development of nasal blockage and sneezing during repeated inhalation challenges with Japanese cedar pollens was evaluated in guinea pigs., Subjects: Male Hartley guinea pigs., Treatment: Guinea pigs were sensitized by intranasal instillation of cedar pollen extracts + Al(OH)3 2 times a day for 7 days. The animal was then forced to inhale the pollens for challenge, which was restrictively trapped in the upper airways, once a week., Methods: Change of specific airway resistance (sRaw), sneezing frequency, and titers of anaphylactic antibodies in the serum were measured after each of the 30 challenges., Results: At the first challenge, no obvious increase in sRaw was observed. However, the second and third challenges to the animals caused modest biphasic elevations of sRaw, with peaks at the first and the fourth to sixth hour. At the fourth to tenth challenges, marked elevations of sRaw were observed. However, with repetition of the inhalation challenge, the early and the late responses became almost indistinguishable because of partial overlapping as the responses expanded. All guinea pigs sneezed immediately after each pollen inhalation challenge. Apparent increases of both circulating gamma1 and IgE antibodies were seen after the seventh challenge., Conclusions: These results indicate that the experimental allergic rhinitis established in the present study can be a valuable model for analyzing the pathogenesis of the disease and developing new therapeutic drugs.
- Published
- 1998
- Full Text
- View/download PDF
37. Effects of anti-IL-5 monoclonal antibody on the murine model of nasal allergy.
- Author
-
Asakura K, Saito H, Watanabe M, Ogasawara H, Matsui T, and Kataura A
- Subjects
- Allergens adverse effects, Allergens immunology, Allergens pharmacology, Animals, Antibodies, Monoclonal adverse effects, Antibodies, Monoclonal immunology, Disease Models, Animal, Dose-Response Relationship, Drug, Drug Hypersensitivity immunology, Drug Hypersensitivity therapy, Drug Interactions, Eosinophilia immunology, Histamine administration & dosage, Histamine adverse effects, Histamine immunology, Histamine H1 Antagonists immunology, Histamine H1 Antagonists pharmacology, Injections, Intraperitoneal, Interleukin-5 adverse effects, Interleukin-5 pharmacology, Mice, Mice, Inbred BALB C, Nasal Cavity drug effects, Nasal Mucosa drug effects, Nasal Mucosa immunology, Nasal Provocation Tests, Respiratory Hypersensitivity etiology, Rhinitis immunology, Sneezing drug effects, Sneezing immunology, Time Factors, Antibodies, Monoclonal pharmacology, Interleukin-5 immunology, Nasal Cavity immunology, Respiratory Hypersensitivity immunology
- Abstract
IL-5 is known to be closely related to the infiltration, activation and proliferation of eosinophils. In this study, we evaluated the in vivo effects of anti-IL-5 monoclonal antibody (mAb) in the murine model of nasal allergy. The mAb treatment inhibited the antigen-induced late phase eosinophilia, but had no effects on the number of basophilic cells. It also inhibited early phase nasal symptoms, and tended to inhibit histamine hypersensitivity. These findings suggest that IL-5 plays an important role in the pathogenesis of allergic nasal disorders.
- Published
- 1998
- Full Text
- View/download PDF
38. IL-8 and the activation of eosinophils and neutrophils following nasal allergen challenge.
- Author
-
Jacobi HH, Poulsen LK, Reimert CM, Skov PS, Ulfgren AK, Jones I, Elfman LB, Malling HJ, and Mygind N
- Subjects
- Adult, Blood Proteins drug effects, Blood Proteins metabolism, Data Interpretation, Statistical, Dose-Response Relationship, Drug, Eosinophil Granule Proteins, Eosinophils drug effects, Eosinophils metabolism, Female, Humans, Interleukin-8 administration & dosage, Male, Nasal Lavage Fluid chemistry, Nasal Lavage Fluid immunology, Neutrophils drug effects, Neutrophils metabolism, Peroxidase drug effects, Peroxidase metabolism, Sneezing drug effects, Sneezing immunology, Eosinophils immunology, Interleukin-8 immunology, Nasal Provocation Tests, Neutrophils immunology, Ribonucleases
- Abstract
Background: A growing body of evidence suggests that proinflammatory cytokines play a role in allergic inflammation by attracting and activating inflammatory cells. In this study, we have investigated the relationship between interleukin-8 (IL-8) in nasal lavage fluid and the local activation of eosinophils and neutrophils following nasal allergen challenge of allergic patients., Methods: Nasal challenges were performed with grass pollen extract in 14 allergic patients and 5 nonallergic controls. Nasal lavage fluid was collected repeatedly for 10 h, and the levels of eosinophil cationic protein (ECP) and myeloperoxidase (MPO) were used as markers of eosinophil and neutrophil activation, respectively. The levels of these molecules were compared with that of IL-8 in nasal lavage fluid., Results: Allergen challenge of allergic patients produced a significant late-phase increase in the levels of ECP and MPO. Furthermore, the level of MPO showed a highly significant correlation with the level of IL-8 in lavage fluid (r = 0.8, p< 0.0001), whereas there was no significant relationship between the levels of ECP and IL-8., Conclusion: Interestingly, our findings suggest that both eosinophils and neutrophils are activated following nasal allergen challenge. In addition, our results are consistent with the hypothesis that IL-8 acts as a chemoattractant/activator of neutrophils during the late phase of the allergic inflammation. In contrast, we were not able to demonstrate any significant relationship between the level of IL-8 in lavage fluid and the activation of eosinophils.
- Published
- 1998
- Full Text
- View/download PDF
39. Nasal immunotherapy--not to be sneezed at.
- Author
-
Haselden BM and Kay AB
- Subjects
- Administration, Intranasal, Allergens administration & dosage, Humans, Rhinitis, Allergic, Seasonal therapy, Sneezing drug effects, Sneezing immunology, T-Lymphocytes drug effects, T-Lymphocytes immunology, Allergens immunology, Immunotherapy
- Published
- 1998
- Full Text
- View/download PDF
40. Histamine and tryptase in nasal lavage fluid following challenge with methacholine and allergen.
- Author
-
Jacobi HH, Skov PS, Kampen GT, Poulsen LK, Reimert CM, Bindslev-Jensen C, Praetorius C, Malling HJ, and Mygind N
- Subjects
- Administration, Intranasal, Adult, Allergens administration & dosage, Antibodies, Anti-Idiotypic immunology, Antibodies, Anti-Idiotypic pharmacology, Basophils drug effects, Basophils immunology, Bronchoconstrictor Agents administration & dosage, Chymases, Cross-Over Studies, Dose-Response Relationship, Drug, Female, Histamine metabolism, Humans, Male, Methacholine Chloride administration & dosage, Middle Aged, Nasal Lavage Fluid chemistry, Pollen immunology, Serine Endopeptidases drug effects, Serine Endopeptidases metabolism, Sneezing drug effects, Sneezing immunology, Tryptases, Allergens immunology, Bronchoconstrictor Agents immunology, Histamine immunology, Methacholine Chloride immunology, Nasal Lavage Fluid immunology, Serine Endopeptidases immunology
- Abstract
Background: The level of histamine in nasal lavage fluid has been used as an index of mast cell/basophil activation in a number of studies. Obviously, such an index can only be valid if changes in the secretory activity of nasal glands do not affect the level of histamine in lavage fluid (i.e. hypersecretion, without a simultaneous activation of mast cells/basophils in the nasal mucosa, must not increase the level of histamine)., Objectives: To asses the effect of nasal hypersecretion on histamine levels in lavage fluid., Methods: Nasal challenges were performed with methacholine and allergen in grass pollen-allergic patients and non-allergic controls. Nasal lavage fluid was collected before and repeatedly for nine hours after nasal challenge, and the level of histamine was compared with that of a specific mast cell-derived enzyme, tryptase. In addition, the effect of methacholine on basophils was examined in vitro., Results: Allergen challenge of allergic patients produced sneezing and a significant increase in histamine and tryptase levels, whereas challenge of non-allergic subjects produced no such response. Interestingly, challenge with methacholine also induced a significant increase in histamine levels. This increase was seen in both allergic and non-allergic subjects and it was not associated with any sneezing or increase in tryptase levels, indicating that mast cells were not activated. Furthermore, stimulation of basophils with methacholine did not induce any histamine release in vitro., Conclusions: Apparently, there exists a pool of histamine in the human nose that can be transferred to lavage fluid during glandular hypersecretion. The source of this histamine is yet to be identified. As the level of histamine seems to be affected by the secretory activity of nasal glands, we question the use of this single mediator as an index of mast cell/basophil activation in nasal lavage studies.
- Published
- 1998
- Full Text
- View/download PDF
41. A double-blind study of the discontinuation of ragweed immunotherapy.
- Author
-
Naclerio RM, Proud D, Moylan B, Balcer S, Freidhoff L, Kagey-Sobotka A, Lichtenstein LM, Creticos PS, Hamilton RG, and Norman PS
- Subjects
- Adolescent, Adult, Antigens, Plant, Double-Blind Method, Histamine analysis, Humans, Immunoglobulin E analysis, Immunoglobulin G analysis, Kinins analysis, Middle Aged, Nasal Lavage Fluid chemistry, Nasal Provocation Tests, Peptide Hydrolases analysis, Plant Proteins administration & dosage, Pollen immunology, Recurrence, Rhinitis, Allergic, Seasonal immunology, Seasons, Sneezing immunology, Allergens, Plant Proteins therapeutic use, Rhinitis, Allergic, Seasonal therapy
- Abstract
Background: Immunotherapy effectively treats the symptoms of allergic rhinitis and improves its pathophysiology. We studied whether the effects of immunotherapy on the early response to nasal challenge with antigen and seasonal symptoms persist after discontinuation., Methods: Twenty subjects with ragweed allergy who were receiving immunotherapy and who had nasal challenges performed before initiation of treatment were selected. The patients had been receiving maintenance therapy with aqueous ragweed extract at a dose of 12 microg of Amb a 1 equivalent for a minimum of 3 years, at which point they were randomized to receive either placebo injections or to continue with the maintenance dose. Nasal challenges were performed before and 1 year after randomization. Nasal challenges were monitored by counting the number of sneezes and measuring histamine, N-alpha-tosyl-L-arginine methyl ester-esterase activity, and kinins in recovered nasal lavages. In the same year symptom diaries were collected during the ragweed season., Results: The initial immunotherapy significantly reduced responses to nasal challenge in both groups. The group continuing to receive active treatment showed no significant changes from the response before randomization. In contrast, the group randomized to placebo treatment showed a partial return of histamine, kinins, and N-alpha-tosyl-L-arginine methyl ester-esterase in nasal secretions and the numbers of sneezes. IgG antibodies to ragweed declined only in the group switched to placebo treatment. Seasonal rises of IgE antibodies to ragweed did not return during the first season after treatment was stopped. Symptoms reported during the ragweed season were not different between the groups., Conclusions: One year after discontinuation of ragweed immunotherapy, nasal challenges showed partial recrudescence of mediator responses even though reports during the season appeared to indicate continued suppression of symptoms.
- Published
- 1997
- Full Text
- View/download PDF
42. Evaluation of threshold criteria for the nasal histamine challenge test in perennial allergic rhinitis.
- Author
-
Kanthawatana S, Maturim W, Fooanant S, Manorot M, and Trakultivakorn M
- Subjects
- Adolescent, Adult, Child, Female, Histamine administration & dosage, Humans, Male, Middle Aged, Nasal Mucosa metabolism, Nasal Obstruction diagnosis, Pruritus diagnosis, Pruritus immunology, Sensitivity and Specificity, Severity of Illness Index, Sneezing immunology, Histamine pharmacology, Nasal Provocation Tests methods, Rhinitis, Allergic, Perennial diagnosis
- Abstract
Nasal reactivity to histamine was determined in patients with perennial allergic rhinitis and in control subjects. A histamine titration method delivered by a metered dose pump was used. Stuffiness, itching, and the number of sneezes were recorded, nasal secretions measured, and nasal airway resistance was recorded by active anterior rhinomanometry. Increased nasal reactivity to histamine was observed among rhinitic patients and inversely correlated with the severity of nasal symptoms. A 3-fold increase of post-saline nasal airway resistance (NAR) best differentiated the nasal responses to histamine in rhinitic patients from those in control subjects. A histamine dose of < or = 2.5 microg provoked a 3-fold increase in NAR, strongly suggesting moderate or severe symptomatic rhinitis in most cases. Nasal provocation techniques might be a useful tool for objectively assessing disease severity and response to treatment in perennial allergic rhinitis.
- Published
- 1997
43. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine.
- Author
-
Baroody FM, Ford S, Lichtenstein LM, Kagey-Sobotka A, and Naclerio RM
- Subjects
- Adult, Airway Resistance immunology, Analysis of Variance, Dose-Response Relationship, Drug, Double-Blind Method, Female, Humans, Linear Models, Male, Mast Cells immunology, Mast Cells metabolism, Methacholine Chloride, Middle Aged, Parasympathetic Nervous System immunology, Poaceae, Rhinitis, Allergic, Seasonal physiopathology, Severity of Illness Index, Sneezing immunology, Time Factors, Allergens, Atropine pharmacology, Histamine analysis, Histamine Release drug effects, Histamine Release immunology, Nasal Lavage Fluid chemistry, Nasal Provocation Tests, Pollen, Premedication methods, Rhinitis, Allergic, Seasonal diagnosis, Rhinitis, Allergic, Seasonal immunology
- Abstract
We enrolled nine allergic subjects in a double blind, placebo-controlled study to examine the effect of premedication with 0.6 mg of atropine on nasal antigen challenge. The challenge consisted of unilaterally stimulating the nasal septum with diluent followed by three increasing doses of antigen and recording responses bilaterally. Sneezes, symptoms, and nasal airway resistance (NAR) were recorded. Secretions were collected using preweighed filter paper discs and histamine was measured. Antigen challenge with the subjects on placebo led to significant dose-dependent increases in sneezes, symptom scores, ipsilateral and contralateral secretion weights, ipsilateral NAR, and total amount of ipsilateral histamine (p < 0.05 versus diluent). Bilaterally applied atropine led to significant inhibition of ipsilateral and contralateral nasal secretions as well as rhinorrhea scores (p < 0.05 versus placebo) but had no significant effect on other parameters. Challenge after atropine premedication led to higher increases in histamine concentration than placebo (p < 0.01). These results suggest that parasympathetically stimulated fluids did not contain histamine and diluted the histamine released by mast cells. To support this hypothesis, we challenged the same subjects with methacholine. The concentration of histamine decreased and was significantly lower than after challenge with antigen (p < 0.01). The data suggest that: (1) histamine is released locally at the site of antigen challenge, (2) the volume of glandular secretions is primarily controlled by parasympathetic stimulation, and (3) the total amount of a mediator recovered in a fixed time interval best reflects the underlying pathophysiologic events.
- Published
- 1994
- Full Text
- View/download PDF
44. The effects of anti-PAF and other agents on the nasal symptoms in sensitized guinea pigs.
- Author
-
Narita S and Asakura K
- Subjects
- Airway Resistance immunology, Animals, Chromones pharmacology, Guinea Pigs, Histamine H1 Antagonists pharmacology, Immunization, Lipoxygenase Inhibitors pharmacology, Male, Ovalbumin immunology, Phthalazines pharmacology, Pyrilamine pharmacology, Rhinitis, Allergic, Perennial immunology, SRS-A antagonists & inhibitors, Sneezing drug effects, Sneezing immunology, Thiazolidines, Airway Resistance drug effects, Azepines pharmacology, Platelet Activating Factor antagonists & inhibitors, Rhinitis, Allergic, Perennial physiopathology, Thiazoles pharmacology, Triazoles pharmacology
- Abstract
To define the role of platelet activating factor (PAF) in allergic rhinitis, we examined the effects of anti-PAF agents (WEB2086, SM10661) on the changes of nasal airway resistance (NAR) and nasal symptoms after topical antigen challenge in actively sensitized guinea pigs and compared these with the changes brought by anti-leukotriene (LT) agent (FPL 55712), 5-lipoxygenase inhibitor (E6080), anti-allergic agent (azelastine), and anti-histamine agent (mepyramine maleate). We noted biphasic increase in NAR after antigen challenge; the first peak, 146.3 +/- 4.3% at 10 min and the second peak, 163.3 +/- 7.8% at 240 min after antigen challenge. The first peak response of NAR was not affected by anti-PAF agents, anti-LT agent, 5-lipoxygenase inhibitor, or azelastine; it was slightly but significantly inhibited by anti-histamine. The second NAR response was significantly inhibited by anti-PAF agents, anti-LT agent, 5-lipoxygenase inhibitor, and azelastine, but was not affected by anti-histamine. The nasal symptoms which occurred within 30 min after antigen challenge were significantly inhibited by WEB2086, E6080, azelastine, and mepyramine, but were not affected by SM10661. Our results suggest that PAF activities and LTs may play an important role in the later phase increase of NAR after topical antigen challenge.
- Published
- 1993
- Full Text
- View/download PDF
45. When we sneeze, does the immune system catch a cold?
- Author
-
Openshaw PJ
- Subjects
- Child, Preschool, Humans, Measles immunology, Measles prevention & control, Respiratory Tract Infections complications, Vaccination, Meningitis, Meningococcal complications, Respiratory Tract Infections immunology, Sneezing immunology
- Published
- 1991
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.